LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,988,000 | -2.2% | 40,000,000 | 0.0% | 1.44% | +6.3% |
| Q4 2021 | $39,863,000 | -0.8% | 40,000,000 | 0.0% | 1.36% | -4.0% |
| Q3 2021 | $40,182,000 | +1.5% | 40,000,000 | 0.0% | 1.41% | -3.9% |
| Q2 2021 | $39,571,000 | -19.7% | 40,000,000 | -15.8% | 1.47% | -24.8% |
| Q1 2021 | $49,299,000 | -12.8% | 47,500,000 | -20.8% | 1.96% | -19.8% |
| Q4 2020 | $56,517,000 | +4.1% | 60,000,000 | 0.0% | 2.44% | +21.0% |
| Q3 2020 | $54,281,000 | +3.0% | 60,000,000 | 0.0% | 2.02% | +14.4% |
| Q2 2020 | $52,680,000 | +6.0% | 60,000,000 | 0.0% | 1.76% | +0.3% |
| Q1 2020 | $49,708,000 | -11.5% | 60,000,000 | -7.7% | 1.76% | +34.1% |
| Q4 2019 | $56,160,000 | -2.7% | 65,000,000 | -5.8% | 1.31% | +5.1% |
| Q3 2019 | $57,704,000 | -3.9% | 69,000,000 | -1.4% | 1.25% | +2.3% |
| Q2 2019 | $60,020,000 | – | 70,000,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |